These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4995391)

  • 21. [Cirrhosis secondary to chronic autoimmune hepatitis].
    Michel H; Blanc P
    Rev Prat; 1991 May; 41(13):1157-60. PubMed ID: 2063115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Icterigenic hepatitis with cirrhogenic development with antinuclear antibodies (lupoid hepatitis?)].
    Vachon A; Téte R; Gauthier J; Chapuy H; Silie M
    Arch Fr Mal App Dig; 1968; 57(8):657-76. PubMed ID: 5308996
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)].
    Aprosina ZG; Mukhin AS
    Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432
    [No Abstract]   [Full Text] [Related]  

  • 24. [Modern clinical picture of the problem of hepatitis and cirrhosis].
    Tareev EM
    Sov Med; 1977 Dec; (12):3-14. PubMed ID: 341353
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of active chronic hepatitis with 6-mercaptopurine.
    Sjöberg KH; Welin G
    Acta Hepatosplenol; 1967; 14(3):157-62. PubMed ID: 4172443
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidence of chronic hepatitis and postnecrotic liver cirrhosis following acute viral hepatitis in aged patients].
    Boroń P; Szpakowicz T; Pawińska T
    Przegl Epidemiol; 1976; 30(2):169-73. PubMed ID: 935541
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunoprevention and immunosuppression of chronic inflammatory liver diseases].
    Scheiffarth F
    Med Welt; 1974 Oct; 25(40):1589-92. PubMed ID: 4444495
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic active liver disease reexamined: prognosis hopeful.
    Summerskill WH
    Gastroenterology; 1974 Mar; 66(3):450-64. PubMed ID: 4591728
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy of the chronic aggressive hepatitis with D-penicillamine].
    Alexander M
    Verh Dtsch Ges Inn Med; 1971; 77():1303-6. PubMed ID: 5156012
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppressive therapy. 1.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lupoid hepatitis].
    Juszczyk J
    Pol Tyg Lek; 1968 Jul; 23(31):1175-8. PubMed ID: 4880843
    [No Abstract]   [Full Text] [Related]  

  • 32. [Active chronic hepatitis. Criteria adopted and results in recent specialist studies].
    Carotti A
    Minerva Med; 1980 Nov; 71(47):3429-34. PubMed ID: 7454095
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy.
    Donnelly S; Levison DA; Doyle DV
    Br J Rheumatol; 1993 Mar; 32(3):251-3. PubMed ID: 8448620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary chronic hepatitis. Anatomoclinical and etiological entities].
    Dediu S
    Med Interna (Bucur); 1968 May; 20(5):541-55. PubMed ID: 5735427
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic hepatitis: taxonomic, etiologic, and therapeutic problems.
    Popper H; Schaffner F
    Prog Liver Dis; 1976; 5():531-58. PubMed ID: 775554
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of chronic hepatitis and liver cirrhosis with 6-mercaptopurine and a methylhydrazine derivative].
    Göggel KH; Epperlein H
    Med Klin; 1965 Aug; 60(34):1362-8. PubMed ID: 5843139
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis].
    Gichev IuP; Bakulina LF
    Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399
    [No Abstract]   [Full Text] [Related]  

  • 39. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

  • 40. [Classification of chronic hepatitis and transition to the hepatic cirrhosis].
    Okumura H
    Naika; 1971 Apr; 27(4):771-4. PubMed ID: 5553515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.